Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
QuintilesIMS
Medtronic
Mallinckrodt
US Department of Justice

Generated: September 18, 2019

DrugPatentWatch Database Preview

Panitumumab - Biologic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for panitumumab
Tradenames:1
Patents:264
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for panitumumab
Pharmacology for panitumumab
Ingredient-typeAntibodies, Monoclonal
Mechanism of ActionHER1 Antagonists

US Patents for panitumumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Try a Free Trial VentiRx Pharmaceuticals, Inc. (Seattle, WA) 2030-04-21 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Try a Free Trial University of Georgia Research Foundation, Inc. (Athens, GA) 2038-10-10 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Try a Free Trial Roche Molecular Systems, Inc. (Pleasanton, CA) 2031-01-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for panitumumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2008001,C0979246 Lithuania   Try a Free Trial PRODUCT NAME: PANITUMUMABUM; REGISTRATION NO/DATE: EU/1/07/423/001, EU/1/07/423/002, EU/1/07/423/003 20071203
C005/2008 Ireland   Try a Free Trial SPC005/2008: 20081105, EXPIRES: 20221202
2008 003 Romania   Try a Free Trial PRODUCT NAME: PANITUMUMAB; NATIONAL AUTHORISATION NUMBER: RO EU/1/07/423/001, RO EU/1/07/423/002, RO EU/1/07/423/003; DATE OF NATIONAL AUTHORISATION: 20071203; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/07/423/001, EU/1/07/423/002, EU/1/07/423/003; DATE OF FIRST AUTHORISATION IN EEA: 20071203
C0006 France   Try a Free Trial PRODUCT NAME: PANITUMUMAB; REGISTRATION NO/DATE: EU/1/07/423/001 20071203
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Chinese Patent Office
US Department of Justice
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.